You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes

Citation Tools

Article menu

Download PDFPDF

XML
Emerging technologies, pharmacology and therapeutics
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mora PF, Sutton DR, Gore A, et al
Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
BMJ Open Diabetes Research and Care 2020;8:e001832. doi: 10.1136/bmjdrc-2020-001832